R01DA052214

Spatio-Temporal Methods for Surveillance of the Opioid Syndemic - Project Summary/Abstract

The United States is in the midst of a public health crisis due to the ongoing opioid syndemic. The opioid syndemic consists of the inter-related epidemics of opioid misuse, fatal and non-fatal overdose, human immunodeficiency virus (HIV), and hepatitis C (HCV). The consequences of opioid misuse are particularly severe in Ohio as the state has experienced overdose rates that are double the national average, as well as elevated risk for epidemic levels of HIV and HCV.

A key need for addressing the syndemic is to improve surveillance science methodology to better measure community-levels of opioid misuse and be able to identify and target areas of emerging risk with resources. However, no single data source currently observed by the public health surveillance system fully characterizes opioid misuse at relevant spatial and temporal supports. Novel statistical methods are needed to better leverage existing data and appropriately integrate multiple imperfect surveillance outcomes across different spatial scales to comprehensively estimate levels of opioid misuse and model the syndemic over space and time. Doing so will enable estimation and inference at small areas that are relevant to local policymakers and public health officials while accounting for measurement error.

There are several methodological challenges that will be overcome with the achievement of the following aims:

1) Develop and assess a spatio-temporal factor model that estimates a factor that can be meaningfully interpreted longitudinally.

2) Develop and assess a spatial factor model that allows for outcomes to have different spatial supports.

3) Develop and assess a multivariate spatio-temporal model to estimate areal prevalence of latent opioid misuse.

Successful development of a comprehensive model of the opioid syndemic will advance surveillance science and will produce estimates of opioid misuse that advance epidemiological understanding and provide valuable information to policymakers and public health officials.

Wake Forest University Health Sciences

TO SUPPORT BASIC AND CLINICAL NEUROSCIENCE, BIOMEDICAL, BEHAVIORAL AND SOCIAL SCIENCE, EPIDEMIOLOGIC, HEALTH SERVICES AND HEALTH DISPARITY RESEARCH. TO DEVELOP NEW KNOWLEDGE AND APPROACHES RELATED TO THE PREVENTION, DIAGNOSIS, TREATMENT, ETIOLOGY, AND CONSEQUENCES OF DRUG ABUSE AND ADDICTION, INCLUDING HIV/AIDS. TO SUPPORT RESEARCH TRAINING AND RESEARCH SCIENTIST DEVELOPMENT. TO SUPPORT DISSEMINATION OF RESEARCH FINDINGS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) LEGISLATION IS INTENDED TO EXPAND AND IMPROVE THE SBIR PROGRAMS TO EMPHASIZE AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF TECHNOLOGY DEVELOPED THROUGH FEDERAL SBIR RESEARCH AND DEVELOPMENT, INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN THE SBIR PROGRAM. THE LEGISLATION INTENDS THAT THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.

93.279 - Drug Abuse and Addiction Research Programs

National Institute on Drug Abuse (NIDA) [HHS - NIH]

Winston Salem, North Carolina 27157 United States

Single Zip Code

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) (PA-20-185)

Amendment Since initial award the End Date has been extended from 06/30/25 to 08/31/29 and the total obligations have increased 867% from $387,459 to $3,748,657.